COMMUNIQUÉS West-GlobeNewswire

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
14/05/2025
Revenue for the First Quarter Ended March 31, 2025 was $13.1 million Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) Commercial Launch Off to a Strong Start, Initial Prescriptions Filled in Late [...]
Whoopi Goldberg to Participate in Fireside Chat at CMB, Launching Hemp-Derived Beverage “Whoop-Tea”
14/05/2025
Leading Cannabis Means Business (CMB) Trade Show and Conference Takes Place June 4-5 at the Javits Center in New York NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Cannabis Means Business (CMB) is thrilled to announce that [...]
Minutes of the General Meeting of 14 May 2025 and additional information on the plan to reinforce the financial position
14/05/2025
Press release 14 May 2025 Minutes of the General Meeting of 14 May 2025 - additional information on the progress of the plan to reinforce its financial structure Paris, 14 May 2025 – The Annual General Meeting of [...]
Compte-rendu de l'Assemblée générale du 14 mai 2025 et précision sur l'avancement du Plan de renforcement de la structure financière
14/05/2025
Communiqué de presse Compte rendu de l’Assemblée générale du 14 mai 2025 - précision sur l’avancement du plan de renforcement de la structure financière Paris, le 14 mai 2025 – L’Assemblée générale annuelle des [...]
Aptose Selected for Prestigious Oral Presentation of Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2025 EHA Congress
14/05/2025
Aptose is developing TUS+VEN+AZA as a one-of-a-kind safe and mutation agnostic frontline triple drug therapy for newly diagnosed AML Oral presentation at EHA will include updated data at the 40 mg and 80 mg dose levels [...]
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
14/05/2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 14 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the [...]
RAMSAY SANTE : Interim results at the end of March 2025
14/05/2025
PRESS RELEASE Paris, 14 th May 2025 Interim results at the end of March 2025 Activity growth and cost control compensate pricing headwinds Unaudited group revenue for the nine months period ending 31 March 2025 [...]
RAMSAY SANTE : Résultats intermédiaires au 31 mars 2025
14/05/2025
COMMUNIQUÉ DE PRESSE Paris, le 14 mai 2025 Résultats intermédiaires au 31 mars 2025 Croissance de l'activité et contrôle des coûts compensent une tarification défavorable Le chiffre d’affaires non audité du groupe pour [...]
Best Creatine For Men 2025: Top Athlete-Tested Supplements for Muscle Growth, Strength & Recovery
14/05/2025
Discover the best creatine for men to boost muscle growth and recovery. See why Crazy Nutrition’s Ultimate CRN-5 is the top athlete pick for real strength results in 2025. Glasgow, May 14, 2025 (GLOBE NEWSWIRE) -- [...]
Sevaro Launches Nationwide Stroke Awareness Campaign With Racecars, Storybooks, and Student Heroes
14/05/2025
CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- A stroke happens every 40 seconds in the U.S.—and every minute without treatment can cost a person 1.9 million brain cells. This May, during Stroke Awareness Month [...]
The Best Steroids for Cutting, Muscle Growth & Strength for Weight Training - Top Legal Steroid Stacks for Bulking, Fat Loss, Getting Shredded & Ripped - CrazyBulk
14/05/2025
New York City, NY, May 14, 2025 (GLOBE NEWSWIRE) -- For serious bodybuilders and weightlifters, achieving fast muscle growth and that shredded look takes more than just hard work in the gym. The right steroid stack will [...]
Genmab to Present New and Updated Results from its Robust Epcoritamab (EPKINLY®) Development Program at the 2025 European Hematology Association (EHA) Congress
14/05/2025
Media Release COPENHAGEN, Denmark; May 14, 2025 Data from 14 abstracts highlight the depth, breadth, and strength of Genmab’s comprehensive epcoritamab development program across multiple patient populations and [...]
REPEAT/Media Advisory/OHC - Day of Action at Ontario Legislature to Stop Hospital Closures
14/05/2025
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- On Wednesday May 14, people from across Ontario will be heading into the Ontario Legislature for a “Day of Action” to ask the Ford government to stop closing their local [...]
Kura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) Congress
14/05/2025
– Ziftomenib combined with 7+3 in 1L NPM1 -m or KMT2A -r AML patients selected for oral presentation on Thursday, June 12th – – Updated dataset to be presented in oral presentation at EHA2025 Congress – SAN DIEGO and [...]
Therini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline
14/05/2025
- Angelini Ventures and Apollo Health Ventures join existing top-tier investor syndicate - Follows original $36M Series A raise and brings Series A total to $75M - Proceeds are being used to fund Phase 1b Alzheimer’s [...]
Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress
14/05/2025
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced [...]
Angelini Ventures Invests into $39 Million Series A Extension Round for Therini Bio, a Clinical Stage Company Developing Fibrin-targeting Immunotherapies for Neurodegenerative Diseases
14/05/2025
Angelini Ventures joins top-tier investor syndicate Investment will fund Phase 1b studies evaluating Therini Bio’s lead candidate, THN391, for the treatment of Alzheimer’s Disease (AD) and Diabetic Macular Edema (DME), [...]
Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June
14/05/2025
Preclinical studies achieved therapeutically relevant gene editing levels of the HBG1/2 promoter & favorable biodistribution profile in non-human primates using a clinically validated editing strategy Data [...]
Nurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant Lymphoma
14/05/2025
SAN FRANCISCO, May 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]

Pages